MohamedAliEl-ShahawyMDMPH,MHA,FASN

Nephrology • Los Angeles, CA

Chronic Renal Failure & Dialysis

Professor of Medicine

Join to view full profile

Dr. El-Shahawy is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. El-Shahawy's full profile

Already have an account?

Office
5830 Whittier Blvd
Los Angeles, CA 90022
Phone+1 323-725-0051

Fax+1 323-869-9245

Education & Training

UPMC Medical EducationFellowship, Nephrology, 1986 - 1988
St Mary's Hospital (Waterbury)Residency, Internal Medicine, 1983 - 1986
Cairo University School of MedicineClass of 1979

Certifications & Licensure

CA State Medical License 1985 - 2025
WV State Medical License 1988 - 2014
MA State Medical License 1987 - 2005
PA State Medical License 1985 - 2002
CT State Medical License 1985 - 1988
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Nephrology

Clinical Trials

A Study Comparing Dulaglutide With Insulin Glargine on Glycemic Control in Participants With Type 2 Diabetes (T2D) and Moderate or Severe Chronic Kidney Disease (CKD) Start of enrollment: 2012 Jul 01
Completed
Phase 3
Efficacy and Safety of Tolvaptan in Subjects With Chronic Kidney Disease Between Late Stage 2 to Early Stage 4 Due to Autosomal Dominant Polycystic Kidney Disease Start of enrollment: 2014 May 01
Completed
Phase 3
A Phase 2/3 Trial of the Efficacy and Safety of Bardoxolone Methyl in Patients With Alport Syndrome - CARDINAL Start of enrollment: 2017 Mar 02
Completed
Phase 2, Phase 3
An Extended Access Program for Bardoxolone Methyl in Patients With CKD (EAGLE) Start of enrollment: 2019 Mar 08
Terminated
Phase 3
Efficacy and Safety of Lorundrostat Alone, and in Combination With Dapagliflozin in Subjects With Hypertension and Chronic Kidney Disease (CKD) With Albuminuria Start of enrollment: 2023 Dec 14
Recruiting
Phase 2
Roles: Contact
Join now to see all

Publications & Presentations

PubMed

61 citations
Roxadustat Versus Epoetin Alfa for Treating Anemia in Patients with Chronic Kidney Disease on Dialysis: Results from the Randomized Phase 3 ROCKIES Study.
Steven Fishbane, Carol A Pollock, Mohamed El-Shahawy, Elizabeth T Escudero, Anjay Rastogi
Journal of the American Society of Nephrology. 2022-04-01
1 citations
Authors' Reply.
Steven Fishbane, Mohamed A El-Shahawy, Bui Pham Van, Dustin J Little
Journal of the American Society of Nephrology. 2021-06-01
94 citations
Roxadustat for Treating Anemia in Patients with CKD Not on Dialysis: Results from a Randomized Phase 3 Study
Steven Fishbane, Mohamed A. El-Shahawy, Roberto Pecoits-Filho, Bui Pham Van, Mark T. Houser
Journal of the American Society of Nephrology. 2021-02-10

Professional Memberships

American Society of Nephrology - ASN
Member